The Latin America, Middle East and Africa Blood Warmer Market would witness market growth of 11.0% CAGR during the forecast period (2023-2030).
The increasing frequency of illnesses like hypothermia, in which the body temperature lowers, is expected to fuel growth in the market. The body experiences this when the temperature falls below 35 degree C and loses heat faster than it produces. The most common cause of hypothermia is extended exposure to extremely low temperatures. It is also prevalent in infancy, old age, and medical conditions such as dementia, hypothyroidism, and low blood sugar. Hypothermia is another serious risk for trauma patients.
Since hypothermia frequently results in aberrant heart, neurological system, and respiratory system function, various technologies are used to warm the blood to overcome hypothermic situations and reduce the risk of hypothermia. It may result in total heart or breathing system failure, even in extreme circumstances. Therefore, using blood warmers is essential in this situation, and throughout the projection period, rapid growth in the market is predicted.
The essential factors driving the growth of the market are the increasing number of traffic accidents, the resulting increase in trauma cases, and the increased need for blood transfusions in operations across the globe. The prevalence of hypothermia and related illnesses and the rise in disposable income contribute to the market's overall growth.
The United Arab Emirates (UAE) healthcare sector is a significant driver of the country’s economic expansion. Due to escalating healthcare prices in western nations and the absence of insurance coverage for particular procedures like dentistry, and orthopedics, the UAE has become a popular choice for westerners seeking medical care. Around 350,118 tourists travelled to the area in 2019 for medical purposes, according to the Dubai Global Trade Center. The area’s medical facility is considered the sixth best in the world. This further raises the prospects market players in the regional market.
The Brazil market dominated the LAMEA Blood Warmer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $32 million by 2030. The Argentina market is exhibiting a CAGR of 11.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.7% during (2023 - 2030).
Based on Application, the market is segmented into Surgery, Acute Care, New Born Care, Homecare, and Others. Based on Product, the market is segmented into Non-portable Blood/IV Warmers, and Portable Blood/IV Warmers. Based on End-use, the market is segmented into Hospitals/Clinic, Ambulatory Services, Defense Forces, and Rescue Forces. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Blood Warmer Market is Projected to reach USD 1.8 Billion by 2030, at a CAGR of 7.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Stryker Corporation, ICU Medical, Inc., Gentherm Incorporated (Gentherm Medical), Vyaire Medical, Inc. (Apax Partners LLP), Belmont Medical Technologies (Audax Management Company, LLC.), The Surgical Company, Life Warmer, Estill Medical Technologies, Inc., and Smisson-Cartledge Biomedical, LLC.
By Application
By Product
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
